维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Jongh FE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver显示文摘	de Jongh FE Janssen HL de Man RA		0，，05：	1
2	Survival and prognostic indicators in hepatitis B surface antigen -posi- tive cirrhosis of the liver 显示文摘	de JONGH FE JANSSEN HL de MAN RA	1992	Gastroenterology1992，103，5：	1
3	Survival and Prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver显示文摘	De Jongh FE Janssen HLA De Man RA	1992	Gastroenterology1992，103，：	1
4	Acute pancreatitis caused by metronidazole显示文摘	de Jongh FE Ottervanger JP Stuiver PC	1996	Ned Tijdschr Geneeskd1996，140，1：	1
5	Dextromethorphan as a phenotyping test to pre-dict endoxifen exposure in patients on tamoxifen treatment显示文摘	de Graan AJ Teunissen SF de Vos FY Loos WJ van Schaik RH de Jongh FE	2011	J Clin Oncol2011，29，24：	1
6	Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver显示文摘	De Jongh FE Janssen HL de Man RA	1992	Gastroenteroloy1992，103，8：	1
7	A rare cause of abdominal pain显示文摘	Verweij KE de Jongh FE	2011	Neth J Med2011，69，45：	1
8	Evaluation of an alternate dosing strategy for cisplatin inpatients with extreme body surface area values 显示文摘	Loos WJ De Jongh FE Sparreboom A	2006	J Clin Oncol2006，24，10：	1
9	Survival and prognostic indicators in hepatitis B surface antigen positive cirrhosis of liver显示文摘	De Jongh FE Janssen HL De Man RA	1992	Gastroenterology1992，103，11：	1
10	Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients显示文摘	de Jongh FE van Veen RN Veltman SJ	2003	Br J Cancer2003，88，8：	1
11	Body-surface area-based dosing does not increase accuracy of predicting cisplatin expo-sure显示文摘	de Jongh FE Verweij J Loos WJ	2001	J Clin Oncol2001，19，：	1
12	Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver显示文摘	de Jongh FE Janssen HL de Man RA	1992	Gastroenterology1992，103，：	1
13	Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver 显示文摘	de Jongh FE Janssen HL de Man RA	1992	Gastroenterology1992，103，5：	1
14	Population Pharmacokinetics of cisplatin in adult cancer patients显示文摘	De Jongh FE Gallo JM Shen M	2004	Cancer Chemother Pharmacol2004，54，12：	1
15	Survival and prognos-tic indicators in hepatitis B surface antigen-positive cirrhosis of the liver显示文摘	Jongh FE Janssen HL de Man RA etal	1992	Gastroenterology1992，103，：	1
16	Evaluation of an alternate dosing strategy for cisplatin in Patients with extreme body surface area values显示文摘	Loos WJ de Jongh FE Sparreboom A	2006	J Clin Oncol2006，24，10：	1
17	Weekly high- dose eisplatin is a feasible treatment option : analysis on prognostic factors for toxicity in 400 patients 显示文摘	de Jongh FE van Veen RN Veltman SJ	2003	Br J Cancer2003，88，8：	1
18	Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver 显示文摘	de Jongh FE Janssen HL de Man RA	1992	Gastroenterology1992，103，5：	1
19	Evaluation of an al- ternate dosing strategy for cisplatin in patients with extreme body surface area values显示文摘	Loos WJ de Jongh FE Sparreboom A	2006	J Clin Oncol2006，24，10：	1
20	Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver显示文摘	Jongh FE Janssen HL De-Man RA		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示